Literature DB >> 19620198

Prevalence of transient hyperphosphatasemia among healthy infants and toddlers.

Susanna Y Huh1, Henry A Feldman, Joanne E Cox, Catherine M Gordon.   

Abstract

OBJECTIVE: To describe the prevalence and clinical characteristics of transient hyperphosphatasemia (TH) in a cohort of healthy infants and toddlers.
METHODS: We performed a secondary data analysis of healthy infants and toddlers enrolled in a study examining the epidemiology of vitamin D deficiency. From 2005 to 2007, children aged 8 to 24 months were enrolled during well-child visits at an urban primary care pediatric clinic. At enrollment, we collected data regarding sociodemographic and clinical characteristics. We measured serum levels of alkaline phosphatase (AP), 25-hydroxyvitamin D, parathyroid hormone (PTH), calcium, magnesium, and phosphorus. We placed participants into 1 of 3 categories on the basis of serum AP levels: normal (AP: 110-400 U/L), intermediate (AP: >400 to 1000 U/L), and TH (AP: >1000 U/L). We used Fisher's exact test and analysis of variance to evaluate differences in characteristics among the 3 groups.
RESULTS: Nine (2.8%) of 316 children had an AP level of >1000 U/L (mean: 2165 U/L). Sixteen children (5.1%) had an intermediate serum AP level (mean: 544 U/L). Mean weight-for-age, length-for-age, and weight-for-length z scores were similar across all 3 AP groups. Compared with the 291 children without TH, children in the intermediate AP and TH groups had similar mean serum levels of 25-hydroxyvitamin D, PTH, calcium, magnesium, and phosphorus.
CONCLUSIONS: TH seems to be a relatively common condition among healthy infants and toddlers. TH was not associated with anthropometric measures, vitamin D status, PTH, or serum minerals. Recognition of this benign condition is important to avoid unnecessary investigations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620198      PMCID: PMC2886727          DOI: 10.1542/peds.2008-3093

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  27 in total

Review 1.  New biomarkers of bone resorption.

Authors:  D Eyre
Journal:  J Clin Endocrinol Metab       Date:  1992-03       Impact factor: 5.958

2.  Transient hyperphosphatasaemia in association with acute infection in adults.

Authors:  S G Parker
Journal:  Postgrad Med J       Date:  1991-07       Impact factor: 2.401

Review 3.  Defining undernutrition for public health purposes in the United States.

Authors:  K E Peterson; L C Chen
Journal:  J Nutr       Date:  1990-08       Impact factor: 4.798

4.  What is the cause of benign transient hyperphosphatasemia? A study of 35 cases.

Authors:  P M Crofton
Journal:  Clin Chem       Date:  1988-02       Impact factor: 8.327

5.  Simultaneous transient hyperphosphatasemia in a set of twins.

Authors:  J R Kraut; B Shah
Journal:  Am J Dis Child       Date:  1989-08

6.  Benign elevation of serum alkaline phosphatase, transient and persistent variety.

Authors:  V Abbassi; A R Colon; R H Schwartz
Journal:  Clin Pediatr (Phila)       Date:  1984-06       Impact factor: 1.168

7.  Atypical, anodally migrating alkaline phosphatase isoenzyme in children and its relation to abdominal symptoms.

Authors:  H Weiber; G Fex; T Lindberg; G Skude
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

8.  Isoenzyme studies in transient hyperphosphatasemia of infancy. Ten new cases and a review of the literature.

Authors:  J R Kraut; M Metrick; N R Maxwell; M M Kaplan
Journal:  Am J Dis Child       Date:  1985-07

9.  Recurrent transient hyperphosphatasemia of infancy in an adult.

Authors:  D Onica; J Torssander; L Waldenlind
Journal:  Clin Chem       Date:  1992-09       Impact factor: 8.327

10.  Transient hyperphosphatasemia of infancy and early childhood: clinical and biochemical features of 21 cases and literature review.

Authors:  P Stein; S B Rosalki; A Y Foo; M Hjelm
Journal:  Clin Chem       Date:  1987-02       Impact factor: 8.327

View more
  6 in total

1.  Benign transient hyperphosphatasemia in an infant during zinc supplementation.

Authors:  Ayça Bilge Sönmez; İlter Arifoğlu; Ahmet Yıldırım; Filiz Tütüncüler
Journal:  Turk Pediatri Ars       Date:  2018-06-01

2.  Establishment of biochemistry reference values for healthy Tanzanian infants, children and adolescents in Kilimanjaro Region.

Authors:  Ann M Buchanan; Suzanne P Fiorillo; Michael W Omondi; Coleen K Cunningham; John A Crump
Journal:  Trop Med Int Health       Date:  2015-08-25       Impact factor: 2.622

3.  Normal bone turnover in transient hyperphosphatasemia.

Authors:  Stepan Kutilek; Barbora Cervickova; Pavla Bebova; Marie Kmonickova; Vladimir Nemec
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-05-03

4.  A case series of benign transient hyperphosphatasemia from a pediatric endocrinology reference health facility in Turkey.

Authors:  Fatma Dursun; Heves Kirmizibekmez
Journal:  Pan Afr Med J       Date:  2018-07-11

5.  Transient hyperphosphatasemia: Possible association with pediatric acute respiratory infection.

Authors:  Yoshihiko Sakurai; Takafumi Higashiguchi
Journal:  Pediatr Investig       Date:  2021-06-18

6.  Elevated Alkaline Phosphatase in Children: An Algorithm to Determine When a "Wait and See" Approach is Optimal.

Authors:  Jaclyn L Otero; Regino P González-Peralta; Joel M Andres; Christopher D Jolley; Don A Novak; Allah Haafiz
Journal:  Clin Med Insights Pediatr       Date:  2011-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.